Novartis AG (NOVN.SW) SIX
Currency In CHF
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 268.06B |
| Enterprise Value | 293.64B |
| P/E Ratio | 22.01 |
| PEG Ratio | 2.57 |
| Price/Sales Ratio | 5.29 |
| Price/Book Ratio | 7.59 |
| Enterprise/Revenue | 6.01 |
| Enterprise/EBITDA | 14.96 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.24 |
| Operating Margin | 0.3 |
AD
Management Effectiveness
| Return On Assets | 0.11 |
| Return On Equity | 0.32 |
Income Statement
| Revenue | 57.13B |
| Revenue/Share | 29.05 |
| Gross Profit | 42.86B |
| EBITDA | 23.96B |
| Net Income | 14.65B |
| Diluted EPS | 7.49 |
Balance Sheet
| Total Cash | 7B |
| Total Cash/Share | 3.67 |
| Total Debt | 47.14B |
| Total Debt/Equity | 1.22 |
| Current Ratio | 0.85 |
| Book Value Per Share | 20.45 |
Price History
| 52-Week Change | 28.98 |
| 52-Week High | 131 |
| 52-Week Low | 91.2 |
| Moving Average 50 Days | 119.74 |
| Moving Average 200 Days | 114.94 |
Statistics
| Average Volume | 2.77M |
| Shares Outstanding | 1.91B |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 4.57 |
| Trailing Annual Dividend Yield | 2.97 |
| Payout Ratio | 0.61 |
| Last Split Factor | 6:5 |
| Last Split Date | October 04, 2023 |
AD
